about
Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature.Favorable control of advanced colon adenocarcinoma with severe bone marrow metastasis: A case report.Molecular alterations in key-regulator genes among patients with T4 breast carcinoma.High lymphatic vessel density and presence of lymphovascular invasion both predict poor prognosis in breast cancer.Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology.Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future ProspectsDelivering cancer services: a multi-disciplinary approachThe impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis.Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristicsuPAR and HER-2 gene status in individual breast cancer cells from blood and tissues.Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancerIdentification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles.Moving from correlative science to predictive oncology.Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis.Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.High Expression of Three-Gene Signature Improves Prediction of Relapse-Free Survival in Estrogen Receptor-Positive and Node-Positive Breast Tumors.Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers.Genetic polymorphisms of metastasis suppressor gene NME1 and breast cancer survival.DNA copy number aberrations in breast cancer by array comparative genomic hybridization.Molecular markers of breast axillary lymph node metastasis.Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer.Multi-biomarker pattern for tumor identification and prognosis.Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.Treatment response to preoperative anthracycline-based chemotherapy in locally advanced breast cancer: the relevance of proliferation and apoptosis rates.Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression.Plasma VEGF levels in breast cancer patients with and without metastases.Prognostic value of cyclin E expression in breast cancer: a meta-analysis.Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer.Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer.Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis.
P2860
Q30854643-2D747164-8EA7-4574-A299-F247704E21FEQ33437194-E7D5F5A2-A528-4BF5-BCF7-B392FB78E33CQ33671525-AEC1E04B-43E5-4FC2-8C29-AA6D1B57BEC9Q33702827-B786C219-ED81-4170-B531-21BE27E566DBQ33775506-C9E1EABC-3BE4-4AEC-AFD1-A6687E5886E0Q34095769-31E053EB-823E-4C49-9E01-8AF4D92FB060Q34991364-3EADAE11-4F53-4721-AE5A-CAAE1145801BQ35225035-BEE80681-6CAB-4214-BDC1-CEDA7B755FA9Q35611018-8F7B212F-D710-40B9-B15E-0079E6F2C47CQ35720929-54836787-2AA7-417C-82E8-6E082783458AQ35771435-46BEA3CE-1DEB-468E-8782-2C9921327F0DQ36041569-CE6D5935-B251-4E03-AA0A-2430F9211CA8Q36117650-5BEDC60F-336A-4C03-82AF-C02CEA77C2E4Q36182244-64D98CF5-16A7-4D30-9216-1C1CEFB79597Q36251476-3B499BDF-1D7B-44F7-9495-AB15859E27ADQ36338015-400B9689-3D84-49AC-B7AA-8A63E1D8F6B9Q36609527-20678AD2-61E0-4783-A709-5753A2350AF9Q37037132-50CDA260-D59C-4DDA-BE02-8DC50E6FEA67Q37270155-8D4FBAA7-8159-401B-BE63-4A7FBD73D9EAQ37318608-4532EED3-6A32-4763-80FF-52FC6E3D8D95Q37542255-1C5EE1A4-F87F-4F52-9D98-A4A10C4683A9Q37716326-118200B3-BBC2-4A2F-9BA7-784C75526DD7Q37890322-6A3F8377-6A5B-46C4-A6C8-8672139385F7Q38051085-397513CA-5F6E-4443-8152-D3330C42AF13Q38397572-47DA538C-57BD-40A0-9882-4B42F0B139A1Q41045365-00CB2AE6-6921-4828-94E4-E0740A900470Q42323711-F20C7305-6984-42D6-A031-3429A42B8231Q45751455-9E9F0A07-47A4-4ED4-9A8C-6205EF5816CDQ51054802-33CB4E6A-657B-4F90-A7EE-0E3173E2ED13Q51905406-60B14A45-2FEA-4996-AAC3-1A64D08B31E1Q53119241-A09BEA13-9453-4315-995E-BFDB87B467F0Q55516569-7D89334F-FF91-438E-9BE1-DAAA657C2196
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Prognostic and predictive factors revisited.
@ast
Prognostic and predictive factors revisited.
@en
type
label
Prognostic and predictive factors revisited.
@ast
Prognostic and predictive factors revisited.
@en
prefLabel
Prognostic and predictive factors revisited.
@ast
Prognostic and predictive factors revisited.
@en
P1433
P1476
Prognostic and predictive factors revisited.
@en
P2093
Daniel F Hayes
P304
P356
10.1016/J.BREAST.2005.08.023
P577
2005-10-18T00:00:00Z